News for Healthier Living
Macrophage KARAP Blockade Boosts IL-10 and Barrier Repair in Ulcerative Colitis
Researchers have identified KARAP (killer cell activating receptor-associated protein), the protein product of the TYROBP gene, as a macrophage-centered regulator that may shape ulcerative colitis (UC) severity. In patient samples, TYROBP expression was elevated in macrophages and tracked with disease activity markers. In mice, deleting Tyrobp reduced dextran sulfate sodium (DSS)-induced colitis, preserved tight junctions, and strengthened the intestinal barrier. Mechanistically, loss of KARAP improved macrophage mitochondrial homeostasis through mechanistic target of rapamycin (mTOR)/mitophagy signaling, increased interleukin-10 (IL-10) production, and protected epithelial cells. The work positions KARAP as a candidate target for strategies that aim to restore mucosal repair rather than merely suppress inflammation. These findings link an immune adaptor to metabolic control of barrier protection.
November 3, 2026
November 4 2026November 3 2026November 2 2026November 1 2026October 30 2026October 29 2026October 28 2026October 27 2026October 26 2026October 25 2026October 24 2026October 23 2026October 22 2026October 21 2026
|
|
|
|
|